Combined immunodeficiency with CD4 lymphopenia and sclerosing cholangitis caused by a novel loss-of-function mutation affecting IL21R
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Combined immunodeficiency with CD4 lymphopenia and sclerosing cholangitis caused by a novel loss-of-function mutation affecting IL21RCombined immunodeficiencies (CIDs) comprise a heterogeneous group of monogenic disorders manifesting with lymphocyte defects, recurrent infections and dysregulated immune response.Recently, we and others have described clinical and molecular features of the combined immunodeficiency syndromes caused by IL21 or IL21R loss-of-function mutations in humans.To date, only one homozygous mutation in the IL21 and five distinct homozygous mutations in the IL21R gene were identified, however only three have been published so far.1,2 Accordingly, comprehensive clinical and immunological data characterizing this novel type of CID are lacking.Here we report a novel homozygous frame-shift mutation in the IL21R gene of a patient presenting with T-, B-and natural killer (NK)-cell lymphopenia.The patient had eosinophilic duodenitis, sclerosing cholangitis, tinea corporis and otitis media, but no increased frequency of respiratory infections, as described in other IL21R-deficient patients.3 Thus, our report expands on the clinical and functional characteristics of the IL21R deficiency, which may aid early diagnosis leading to improved treatment options.The cytokine IL21 regulates T-and B-cell proliferation and activation, 4,5 and promotes NK-cell cytotoxicity.6 IL21 binds to the IL21R, primarily expressed by lymphocyte populations and other hematopoietic cells, but it can also be found on non-hematopoietic cells including fibroblasts, keratinocytes and intestinal epithelial cells.7,8 IL21R and the interleukin-2 receptor common gamma-chain (IL2RG) form a heterodimer complex which upon IL21 binding initiates downstream signaling by activating Janus kinase 1, 3 (JAK1, JAK3) and inducing signal transducer and activator
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Critical Role for IL-21 in Regulating Immunoglobulin Production
Ozaki, K., Spolski, R., Feng, C. G., Qi, C.-F., Cheng, J., Sher, A., Morse, H. C., Liu, C., Schwartzberg, P. L., & Leonard, W. J. (2002) · Science · doi:10.1126/science.1077002 · Cited by 978 · cited 2×
“CD19 (%) 30 (14-33) 41 (14-33) 28 (14-33) 15 (14-33) 18 (14-33) 15 (14-33)”
Cited by
Genes associated with common variable immunodeficiency: one diagnosis to rule them all?
Bogaert, D. J. A., Dullaers, M., Lambrecht, B. N., Vermaelen, K. Y., De Baere, E., & Haerynck, F. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103690 · Cited by 279
Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches
Wong, C. C., Qian, Y., & Yu, J. (2017) · Oncogene · doi:10.1038/onc.2016.485 · Cited by 262
Leonard, W. J., & Wan, C.-K. (2016) · F1000Research · doi:10.12688/f1000research.7634.1 · Cited by 184
Human hyper-IgE syndrome: singular or plural?
Zhang, Q., Boisson, B., Béziat, V., Puel, A., & Casanova, J.-L. (2018) · Mammalian Genome · doi:10.1007/s00335-018-9767-2 · Cited by 67
Xie, Y., Huang, Y., Li, Z.-Y., Jiang, W., Shi, N.-X., Lu, Y., Cao, G., Yin, Z., & Lin, X.-J. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02001-2 · Cited by 18
Metadata
- Authors
- Erman, B., Bilic, I., Hirschmugl, T., Salzer, E., Cagdas, D., Esenboga, S., Akcoren, Z., Sanal, O., Tezcan, I., & Boztug, K.
- Venue
- Haematologica
- Published
- 2015-03-13
- Volume
- 100
- Issue
- 6
- Pages
- e216-e219
- ISSN
- 0390-6078 (ISSN-L)
- 1592-8721
- OpenAlex
- W2002054316
- Cited by
- 56
- References
- 1
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Combined immunodeficiency with CD4 lymphopenia and sclerosing cholangitis caused by a novel loss-of-function mutation affecting IL21R. https://app.cochat.ai/papers/10.3324/haematol.2014.120980
- The paper
- Erman, B., Bilic, I., Hirschmugl, T., Salzer, E., Cagdas, D., Esenboga, S., Akcoren, Z., Sanal, O., Tezcan, I., & Boztug, K. (2015). Combined immunodeficiency with CD4 lymphopenia and sclerosing cholangitis caused by a novel loss-of-function mutation affecting IL21R. Haematologica. https://doi.org/10.3324/haematol.2014.120980
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.